• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体动力学在心血管疾病中的作用。

The role of mitochondrial dynamics in cardiovascular diseases.

机构信息

Department of AngioCardioNeurology, IRCCS Neuromed, Pozzili, Italy.

Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.

出版信息

Br J Pharmacol. 2021 May;178(10):2060-2076. doi: 10.1111/bph.15068. Epub 2020 May 19.

DOI:10.1111/bph.15068
PMID:32294237
Abstract

The process of mitochondrial dynamics is emerging as a core player in cardiovascular homeostasis. This process refers to the co-ordinated cycles of biogenesis, fusion, fission and degradation to which mitochondria constantly undergo to maintain their integrity, distribution and size. These mechanisms represent an early response to mitochondrial stress, confining organelle portions that are irreversibly damaged and preserving mitochondrial function. Accumulating evidence demonstrates that impairment in mitochondrial dynamics leads to myocardial damage and cardiac disease progression in a variety of disease models, including pressure overload, ischaemia/reperfusion and metabolic disturbance. These findings suggest that modulation of mitochondrial dynamics may be considered as a valid therapeutic strategy in cardiovascular diseases. In this review, we discuss the current evidence about the role of mitochondrial dynamics in cardiac pathophysiology, with a particular focus on the mechanisms underlying the development of cardiac hypertrophy and heart failure, metabolic and genetic cardiomyopathies, ischaemia/reperfusion injury, atherosclerosis and ischaemic stroke. LINKED ARTICLES: This article is part of a themed issue on Cellular metabolism and diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.10/issuetoc.

摘要

线粒体动力学过程正成为心血管稳态的核心环节。该过程是指线粒体不断经历的生物发生、融合、裂变和降解的协调循环,以维持其完整性、分布和大小。这些机制代表了对线粒体应激的早期反应,将不可逆损伤的细胞器部分隔离,从而保护线粒体功能。越来越多的证据表明,线粒体动力学的损伤会导致各种疾病模型中的心肌损伤和心脏疾病进展,包括压力超负荷、缺血/再灌注和代谢紊乱。这些发现表明,调节线粒体动力学可能被视为心血管疾病的一种有效治疗策略。在这篇综述中,我们讨论了线粒体动力学在心脏病理生理学中的作用的现有证据,特别关注心脏肥大和心力衰竭、代谢和遗传性心肌病、缺血/再灌注损伤、动脉粥样硬化和缺血性中风发展的机制。相关文章:本文是关于细胞代谢和疾病的专题的一部分。要查看本节中的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.10/issuetoc.

相似文献

1
The role of mitochondrial dynamics in cardiovascular diseases.线粒体动力学在心血管疾病中的作用。
Br J Pharmacol. 2021 May;178(10):2060-2076. doi: 10.1111/bph.15068. Epub 2020 May 19.
2
Mitochondrial dynamics, mitophagy and cardiovascular disease.线粒体动力学、线粒体自噬与心血管疾病
J Physiol. 2016 Feb 1;594(3):509-25. doi: 10.1113/JP271301. Epub 2016 Jan 15.
3
Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.高胆固醇血症对心肌功能、缺血-再灌注损伤以及预处理、后处理和远程预处理的心脏保护作用的影响。
Br J Pharmacol. 2017 Jun;174(12):1555-1569. doi: 10.1111/bph.13704. Epub 2017 Feb 8.
4
Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials.心脏中的线粒体功能:对机制和治疗潜力的深入了解。
Br J Pharmacol. 2019 Nov;176(22):4302-4318. doi: 10.1111/bph.14431. Epub 2018 Aug 2.
5
Ageing, sex, and cardioprotection.衰老、性别与心脏保护
Br J Pharmacol. 2020 Dec;177(23):5270-5286. doi: 10.1111/bph.14951. Epub 2020 Feb 3.
6
Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.硫化氢预处理通过 SIRT3 依赖的方式改善心肌肥厚中的线粒体功能。
Br J Pharmacol. 2018 Apr;175(8):1126-1145. doi: 10.1111/bph.13861. Epub 2017 Jul 6.
7
Mineralocorticoid receptor in cardiovascular diseases-Clinical trials and mechanistic insights.心血管疾病中的盐皮质激素受体:临床试验与机制见解。
Br J Pharmacol. 2022 Jul;179(13):3119-3134. doi: 10.1111/bph.15708. Epub 2021 Nov 17.
8
Chronic inflammatory diseases, myocardial function and cardioprotection.慢性炎症性疾病、心肌功能与心脏保护
Br J Pharmacol. 2020 Dec;177(23):5357-5374. doi: 10.1111/bph.14975. Epub 2020 Feb 8.
9
Cellular metabolism and diseases.细胞代谢与疾病。
Br J Pharmacol. 2021 May;178(10):2031-2033. doi: 10.1111/bph.15355.
10
New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases.p66Shc在缺血再灌注损伤及其他心血管疾病中的新进展。
Br J Pharmacol. 2017 Jun;174(12):1690-1703. doi: 10.1111/bph.13478. Epub 2016 Apr 14.

引用本文的文献

1
The new perspective of cardiac exercise rehabilitation: based on integrative physiology.心脏运动康复的新视角:基于整合生理学
Front Physiol. 2025 Aug 21;16:1651589. doi: 10.3389/fphys.2025.1651589. eCollection 2025.
2
Astaxanthin mitigates cardiac toxicity induced via doxorubicin by alleviating mitochondrial fission and autophagy in rats.虾青素通过减轻大鼠的线粒体分裂和自噬来减轻阿霉素诱导的心脏毒性。
Sci Rep. 2025 Sep 1;15(1):32114. doi: 10.1038/s41598-025-17253-1.
3
Altered β-Adrenergic System, Cardiac Dysfunction, and Lethal Arrhythmia in a Rat Model of Metabolic Syndrome.
代谢综合征大鼠模型中的β-肾上腺素能系统改变、心脏功能障碍及致死性心律失常
Int J Mol Sci. 2025 Aug 19;26(16):7989. doi: 10.3390/ijms26167989.
4
PGC1α regulates the mitochondrial metabolism response to cyclic stretch, which inhibits neointimal hyperplasia.过氧化物酶体增殖物激活受体γ共激活因子1α(PGC1α)调节线粒体对周期性拉伸的代谢反应,从而抑制内膜增生。
Cell Mol Life Sci. 2025 Aug 8;82(1):303. doi: 10.1007/s00018-025-05790-x.
5
Astragaloside IV Alleviates HO-Induced Mitochondrial Dysfunction and Inhibits Mitophagy Via PI3K/AKT/mTOR Pathway.黄芪甲苷IV通过PI3K/AKT/mTOR通路减轻血红素加氧酶诱导的线粒体功能障碍并抑制线粒体自噬。
Cardiovasc Ther. 2025 Jul 10;2025:9549175. doi: 10.1155/cdr/9549175. eCollection 2025.
6
Inhibiting MARCH5/Mfn2 signaling as an alternative strategy to protect cardiomyocytes from hypoxia-induced mitochondrial dysfunction.抑制MARCH5/Mfn2信号传导作为保护心肌细胞免受缺氧诱导的线粒体功能障碍的替代策略。
Comput Struct Biotechnol J. 2025 Jul 2;27:3045-3065. doi: 10.1016/j.csbj.2025.07.001. eCollection 2025.
7
Aerobic Exercise Alleviates Cardiac Dysfunction Correlated with Lipidomics and Mitochondrial Quality Control.有氧运动减轻与脂质组学和线粒体质量控制相关的心脏功能障碍。
Antioxidants (Basel). 2025 Jun 17;14(6):748. doi: 10.3390/antiox14060748.
8
Interaction between mitochondrial oxidative stress and myocardial fibrosis in the context of diabetes.糖尿病背景下线粒体氧化应激与心肌纤维化之间的相互作用
Front Endocrinol (Lausanne). 2025 Jun 5;16:1596436. doi: 10.3389/fendo.2025.1596436. eCollection 2025.
9
Yellow Wine Polyphenolic Compounds protect against myocardial ischemia-reperfusion injury in rats by activating Nrf2 nuclear translocation to regulate the balance of mitochondrial fission and fusion.黄酒多酚化合物通过激活Nrf2核转位来调节线粒体裂变与融合的平衡,从而保护大鼠免受心肌缺血再灌注损伤。
Front Cardiovasc Med. 2025 May 23;12:1506388. doi: 10.3389/fcvm.2025.1506388. eCollection 2025.
10
Mitochondrial unfolded protein response (UPR) as novel therapeutic targets for neurological disorders.线粒体未折叠蛋白反应(UPR)作为神经系统疾病的新型治疗靶点。
J Cereb Blood Flow Metab. 2025 May 15:271678X251341293. doi: 10.1177/0271678X251341293.